Menu

Hormone Affects “Runner’s High”

Leptin, the satiety hormone produced by fat, affects neuronal signaling in the mouse brain; interference with this pathway can influence the rewarding effects of running in the animals.

Sep 2, 2015
Tracy Vence

WIKIMEDIA, DATABASE CENTER FOR LIFE SCIENCESThe rewarding feelings of running—often called “runner’s high”—are in part modulated by a hormone that affects signaling in the brain, according to a mouse study published in Cell Metabolism this week (September 1). Specifically, knockout of a receptor for the adipose-produced leptin, which inhibits hunger, led mice to nearly double the amount of time spent running compared with their wild-type counterparts.

“Based on these findings, we think that a fall in leptin levels increases motivation for physical activity as a means to enhance exploration and the pursuit of food,” study coauthor Stephanie Fulton, an associate professor of nutrition at the University of Montreal, said in a statement.

In previous studies, reduced levels of leptin have been associated with high endurance in people. The hormone is thought to also play a role in anorexia.

“Our study also suggests that people with lower fat-adjusted leptin levels, such as high-performance marathon runners, could potentially be more susceptible to the rewarding effects of running and thus possibly more inclined to exercise,” noted Fulton, adding that the brain-signaling disruption she and her colleagues observed in knockout mice “could potentially underlie the hyperactivity associated with anorexia.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.